We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Trial of an Interactive CD-Program on 6 Months Readmission Rate in Patients With Heart Failure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00311194
Recruitment Status : Completed
First Posted : April 5, 2006
Last Update Posted : April 5, 2006
Information provided by:

April 3, 2006
April 5, 2006
April 5, 2006
February 1998
Not Provided
Readmission and death rate at 6 months' follow up.
Same as current
No Changes Posted
Knowledge regarding heart failure and its treatment
Same as current
Not Provided
Not Provided
Trial of an Interactive CD-Program on 6 Months Readmission Rate in Patients With Heart Failure
A Randomised, Controlled Trial of an Interactive CD-Program on 6 Months Readmission Rate in Patients With Heart Failure
The purpose of this study is to determine whether extra education of patients with chronic heart failure can reduce 6 months readmission rate to hospital.

The prevalence of heart failure (HF) has increased in the western world and is a major concern due to increasing prevalence and rising health care costs. The prognosis remains poor despite improvement in survival due to treatment with ACE-inhibitors and beta-receptor antagonists. HF has a high rate of readmission and hospitalisation. Some readmissions are ascribed to patients’ lack of compliance, insufficient knowledge about diet, medication and symptoms of heart failure. Education of patients has become an important component in order to increase the patients’ self-care and compliance. Intense education and counselling of patients is recommended in both European and American guidelines for HF.

Several systematic reviews of studies on strategies for improvement of outcomes of heart failure patients after discharge have been published, but very little emphasis has been put on methodological issues, e.g. methods of education. In most programs the methods and equipment used for education and information have only consisted of verbal and written material; computer-based tools seem to be relatively new.

Interactive CD-ROM programs for HF patients can increase patients’ knowledge about heart failure and its treatment. However, no studies have examined the clinical outcome, e.g. rate of readmission.

Comparison: Extra educated patients (interactive CD-ROM education) compared to standard educated patients on readmission rate or death during 6 months.

Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Educational/Counseling/Training
Heart Failure
Behavioral: 6 months readmission rate to hospital
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
July 2002
Not Provided

Inclusion Criteria:

  • Inpatients treated for heart failure with left ventricular ejection fraction (LVEF) < 40 % at echocardiography or at least two of the criteria pulmonary rates, peripheral oedema, a third heart sound and signs of heart failure at chest X-ray.

Exclusion Criteria:

  • Somatic disease or physical handicap with difficulties to communicate or handle the technical equipment, patients with only little knowledge in Swedish, patients with expected problems with compliance due to alcohol/drug abuse or major psychiatric illness, and participation in a trial.
Sexes Eligible for Study: All
Child, Adult, Senior
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Not Provided
Not Provided
Swedish Heart Lung Foundation
  • The Council for Medical Health Care Research in South Sweden
  • The Malmö University Hospital Research and Development Foundation
  • The Skane County Councils Research and Development Foundation
  • The NEPI Foundation
Study Director: Hans Liedholm, MD, PhD Drug and Therapeutics Committee
Study Chair: Agneta Björck Linné, B Pharm, PhD Drug and Therapeutics Committee
Swedish Heart Lung Foundation
May 2002

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP